Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials | Zendy

Stuart J. Connolly | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials

Author(s) -

Stuart J. Connolly

Publication year - 2000

Publication title -

european heart journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.336

H-Index - 293

eISSN - 1522-9645

pISSN - 0195-668X

DOI - 10.1053/euhj.2000.2476

Subject(s) - medicine , hazard ratio , implantable cardioverter defibrillator , amiodarone , ventricular fibrillation , ventricular tachycardia , confidence interval , cardiology , ejection fraction , sudden cardiac death , defibrillation , proportional hazards model , randomized controlled trial , atrial fibrillation , heart failure

Three randomized trials of implantable cardioverter defibrillator (ICD) therapy vs medical treatment for the prevention of death in survivors of ventricular fibrillation or sustained ventricular tachycardia have been reported with what might appear to be different results. The present analysis was performed to obtain the most precise estimate of the efficacy of the ICD, compared to amiodarone, for prolonging survival in patients with malignant ventricular arrhythmia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research